Experts in formulation development
Quotient Sciences' approach to formulation development is based on the physical, chemical, and biopharmaceutic properties of each peptide, and we build robust, fit-for-purpose early development programs that meet Investigational New Drug Application (IND) and other regulatory requirements.
- Peptide characterization and preformulation
- Biopharmaceutics profiling to guide route of delivery and formulation strategy
- Pre-clinical and clinical formulation development and optimization
- Phase I clinical assessment in healthy volunteers
Dosage forms for delivery routes
- Oral, including regional delivery
- Parenteral, including intravenous (IV), subcutaneous (SC), and intramuscular (IM)
- Topical
- Rectal
- Vaginal
Clinical testing capabilities
- First-in-human (FIH) studies
- Relative bioavailability studies to optimize drug delivery technology performance
- Absolute bioavailability studies
- Bioanalysis